Market Overview

Tickers

Articles

Keywords

F1000Research Articles Will Be Listed in PubMed, and Deposited in PubMed Central

LONDON, UNITED KINGDOM--(Marketwire - Jan. 14, 2013) - F1000Research (http://f1000research.com/), the first Open Science publisher, announces that articles published in its innovative publishing system will be listed in PubMed, the world's largest and most-used biomedical literature database.

F1000Research is F1000's new open access publishing program that offers immediate publication followed by a thorough and completely open peer review process, executed after publication. Following recent approval by the National Library of Medicine (NLM)'s Selections group, all articles that pass this peer review process will now be listed in PubMed and deposited within PubMed Central.

F1000Research's acceptance by the NLM Selections group follows agreements confirmed with Elsevier in 2012 for the indexing of F1000Research articles in Scopus and Embase.

For more information, visit http://f1000research.com/.

About F1000Research

F1000Research is a new Open Science publishing program for life scientists. Open Science publishing in F1000Research guarantees:

1. No delay: Research findings, analyses of scientific developments, opinions, comments and all other article types are published without delay. 2. Inclusion of all data: Reports of findings of new research are always accompanied by the complete datasets on which they are based, provided in a form permitting both confirmation and reuse of the data by other researchers. 3. No restriction of access: All research findings are published without any restriction of access - full Open Access. 4. Post-publication peer review: Thorough and innovative refereeing of all research articles is carried out rapidly and efficiently following immediate publication. 5. Open refereeing: All refereeing and commentary is open and transparent, published with the names and affiliations of the referees.